Myocardial dysfunction in subarachnoid haemorrhage (SAH MD) v1
Research type
Research Study
Full title
Epidemiology and sequelae of myocardial dysfunction in subarachnoid haemorrhage (SAH MD)
IRAS ID
154898
Contact name
Nicholas Plummer
Contact email
Sponsor organisation
Lancashire Teaching Hospitals NHS Foundation Trust
Research summary
Complications affecting the heart and lungs following subarachnoid haemorrhage (SAH, a form of bleed on the brain) have been widely documented, and are thought to predict poor neurological outcomes. Biochemical, electrocardiogram (ECG) and echocardiogram (echo) findings have variously been suggested as useful in determining the impact of cardiopulmonary complications and prognosticating for cardiac and neurological outcomes. However the most effective system of monitoring for such complications remains to be determined, and long term follow up of myocardial dysfunction has rarely been performed. We will follow all patients admitted to Critical Care over one year with subarachnoid haemorrhage with repeated echo and ECG recordings. These will be correlated against pre-existing medical conditions, the severity of the neurological injury, and subsequent outcomes to determine risk and protective factors for such heart and lung dysfunction, and their impact on clinical outcomes.
REC name
North West - Greater Manchester South Research Ethics Committee
REC reference
14/NW/1210
Date of REC Opinion
30 Oct 2014
REC opinion
Further Information Favourable Opinion